Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Cruz e Costa (Coimbra, Portugal), I. Farinha (Coimbra, Portugal). Bronchiectasis in alpha1-antitrypsin deficiency. 4359

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Alpha-1-antitrypsin deficiency Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139 Year: 2005 a1-antitrypsin deficiency Source: Eur Respir Monogr 2015; 69: 47-84 Year: 2015 Rare SERPINA1 allele Mwhitstable in patients with Alpha1-antitrypsin deficiency Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 What we have learned about alpha-1-antitrypsin deficiency Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Exacerbations of symptoms in alpha-1-antitrypsin deficiency in the UK Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Reversible dyspnoea in alpha1-antitrypsin deficiency Source: Annual Congress 2011 - ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by Clinical Grand Round - an interactive session Year: 2011 Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 354-360 Year: 2009 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Pulmonary disease in intermediate alpha1-antitrypsin deficient patients Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012